Discover 3,601 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,601
Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).
Does Bladder Instillation Reduce Time to Discharge After Sling Surgery
for
Stress Urinary Incontinence
Location: Beverly Hills CA
Sponsor: Cedars-Sinai Medical Center
Sex: Female
Age: 18+
Code: NCT02277288
Recruiting
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
for
Testicular Cancer
Location: Irvine CA
Sponsor: University of California, Irvine
Sex: Male
Age: 18 - 39
Code: NCT05836688
Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Orange CA, Irvine CA, Beverly Hills CA, Yorba Linda CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07391774
Phase 3, Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: Duarte CA, Vancouver, Houston TX, Edmonton,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06172478
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Location: Orange CA, Newport Beach CA, Glendale AZ, Boulder CO,
Sponsor: Nuvalent Inc.
Sex: All
Age: 18+
Code: NCT06765109
Phase 3, Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Los Angeles CA, Chicago IL, Ann Arbor MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06401356
Phase 3, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Burbank CA, Phoenix AZ, Reno NV, Grand Junction CO,